The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Merck’s RSV preventive antibody for infants is approved by FDA. A recommendation from the Advisory Committee on Immunization Practices must be approved by the director of the CDC or the health ...

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age ...

Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, alleviating some concerns that the new Department of Health and Human ...

RAHWAY, N.J., June 26, 2025--ACIP Recommends Merck’s ENFLONSIA for Prevention of RSV in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season ...

Advisers endorse Merck RSV antibody The advisers also voted 5-2 on Thursday to recommend the use of a new shot that can protect babies from respiratory syncytial virus, ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

Dr. Cody Meissner, who voted to recommend the Merck shot, said June 25 that the result data from Beyfortus in the past RSV season was an “astonishing accomplishment.” In case you missed: RFK ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization. Skip to content. NOWCAST KETV NewsWatch 7 at 6:00.